Leguina-Ruzzi Critical Care (2016) 20:24 DOI 10.1186/s13054-016-1203-y
ERRATUM
Open Access
Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition Alberto Leguina-Ruzzi The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication. Competing interests I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven. Received: 19 January 2016 Accepted: 19 January 2016 Reference 1. Leguina-Ruzzi A. A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20:7.
Submit your next manuscript to BioMed Central and we will help you at every step: • We accept pre-submission inquiries • Our selector tool helps you to find the most relevant journal • We provide round the clock customer support • Convenient online submission • Thorough peer review • Inclusion in PubMed and all major indexing services
Correspondence: [email protected] Hematology and Oncology, Department of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile, Portugal 61, Second Floor, Santiago 8330034, Chile
• Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submit
© 2016 Leguina-Ruzzi. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
ERRATUM
Open Access
Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition Alberto Leguina-Ruzzi The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication. Competing interests I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven. Received: 19 January 2016 Accepted: 19 January 2016 Reference 1. Leguina-Ruzzi A. A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20:7.
Submit your next manuscript to BioMed Central and we will help you at every step: • We accept pre-submission inquiries • Our selector tool helps you to find the most relevant journal • We provide round the clock customer support • Convenient online submission • Thorough peer review • Inclusion in PubMed and all major indexing services
Correspondence: [email protected] Hematology and Oncology, Department of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile, Portugal 61, Second Floor, Santiago 8330034, Chile
• Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submit
© 2016 Leguina-Ruzzi. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
